UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000005818
Receipt number R000006874
Scientific Title An Investigation of the Safety of Continued Treatment with Sorafenib in Patients with Unresectable Hepatocellular Carcinoma after the First Disease Progression
Date of disclosure of the study information 2011/06/21
Last modified on 2018/11/07 09:20:40

No. Disposal Last modified on Item of update
1 Insert 2011/06/21 14:54:32
2 Update 2011/06/21 14:58:20 Date of disclosure of the study information
3 Update 2011/06/22 12:34:58 Institute
Institute
4 Update 2012/06/21 09:24:03 Organization
Organization
Division name
Division name
Address
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2012/06/21 09:28:32 Division name
Institute
Institute
6 Update 2013/10/10 16:32:20 Recruitment status
Last follow-up date
7 Update 2013/12/26 12:45:45 TEL
Email
Address
Address
TEL
8 Update 2014/06/23 09:57:28 Publication of results
9 Update 2018/11/07 00:31:18 Recruitment status
Date of protocol fixation
Anticipated trial start date
10 Update 2018/11/07 09:19:58 Name of primary person or sponsor
Organization
11 Update 2018/11/07 09:20:40 Publication of results